🇺🇸 FDA
Patent

US 7863282

Compositions useful as inhibitors of protein kinases

granted A61PA61P11/06A61P19/08

Quick answer

US patent 7863282 (Compositions useful as inhibitors of protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61P, A61P11/06, A61P19/08, A61P19/10, A61P25/00